Ticker >

Trident Texofab share price

Trident Texofab Ltd.

BSE: 540726 SECTOR: Textile  15k   23   3

48.82
-0.04 (-0.08%)
BSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 54.9

Today's Low

₹ 48

52 Week High

₹ 76.1

52 Week Low

₹ 47.9

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

49.16 Cr.

Enterprise Value

83.75 Cr.

No. of Shares

1.01 Cr.

P/E

39.68

P/B

3.01

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  16.22

CASH

0.06 Cr.

DEBT

34.65 Cr.

Promoter Holding

61.33 %

EPS (TTM)

₹  1.23

Sales Growth

14.32%

ROE

15.8 %

ROCE

13.07%

Profit Growth

125.75 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year14.32%
3 Year1.94%
5 Year2.43%

Profit Growth

1 Year125.75%
3 Year35.07%
5 Year24.22%

ROE%

1 Year15.8%
3 Year8.92%
5 Year9.71%

ROCE %

1 Year13.07%
3 Year10.61%
5 Year11.85%

Debt/Equity

2.2864

Price to Cash Flow

8.4

Interest Cover Ratio

1.73452066605594

CFO/PAT (5 Yr. Avg.)

0.628822962414594

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 61.33 0
Sep 2023 61.33 0
Jun 2023 61.23 0
Mar 2023 61.23 0
Dec 2022 61.09 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.315543589798636.
  • The company has an efficient Cash Conversion Cycle of 89.4111359480732 days.
  • The company has a high promoter holding of 61.33%.

 Limitations

  • The company has shown a poor revenue growth of 1.93792325035564% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 24.55 24.24 23.1 23.2 23.01
Total Expenditure 22.39 23.71 21.67 21.94 21.11
Operating Profit 2.16 0.53 1.43 1.26 1.9
Other Income 0.74 0.89 0.08 1.03 0.11
Interest 0.92 1.09 0.91 1.07 0.93
Depreciation 0.4 0.41 0.41 0.41 0.41
Exceptional Items -0.05 -0.08 -0.36 0 0
Profit Before Tax 1.54 -0.16 -0.17 0.81 0.67
Tax 0.39 -0.21 -0.04 0.06 0.11
Profit After Tax 1.15 0.06 -0.13 0.75 0.56
Adjusted EPS (Rs) 1.14 0.06 -0.13 0.75 0.55

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 86.9 90.96 49.91 84.29 96.36
Total Expenditure 84.5 86.14 47.03 79.5 90.05
Operating Profit 2.4 4.83 2.88 4.79 6.31
Other Income 0.32 0.42 1.85 0.74 1.9
Interest 0.86 2.71 2.85 2.83 3.71
Depreciation 0.3 1.01 1.02 1.47 1.64
Exceptional Items 0.14 0 0.05 0.04 -0.13
Profit Before Tax 1.69 1.53 0.9 1.27 2.73
Tax 0.42 0.63 0.55 0.29 0.51
Net Profit 1.27 0.9 0.35 0.98 2.22
Adjusted EPS (Rs.) 1.33 0.94 0.35 0.98 2.2

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 4.2 4.2 10.07 10.07 10.07
Total Reserves 6.8 7.43 1.91 2.89 5.11
Borrowings 9.25 10.55 19.19 20.27 18.58
Other N/C liabilities 0.01 4.25 6.38 7.51 6.31
Current liabilities 26.79 29.25 30.23 30.25 37.23
Total Liabilities 47.04 55.68 67.77 70.99 77.31
Assets
Net Block 2.36 12.48 14.21 21.71 23.33
Capital WIP 6.39 0.3 8.89 3.62 0
Intangible WIP 0 0 0 0 0
Investments 1.42 1.12 2.48 2.06 3.64
Loans & Advances 0.37 0.41 0.59 0.23 0.22
Other N/C Assets 0.42 1.43 1.6 3.34 3.43
Current Assets 36.08 39.94 40 40.03 46.69
Total Assets 47.04 55.68 67.77 70.99 77.31
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 1.69 1.53 0.9 1.27 2.73
Adjustment 1.24 3.68 2.92 4.64 4.33
Changes in Assets & Liabilities -4.94 -7.56 -1.63 -4.52 -1.07
Tax Paid -0.74 -0.5 -0.23 0 -0.13
Operating Cash Flow -2.75 -2.85 1.96 1.39 5.85
Investing Cash Flow -6.61 -2.41 -10.19 -4.38 0.37
Financing Cash Flow 9.59 4.95 8.19 2.99 -6.2
Net Cash Flow 0.22 -0.31 -0.05 0 0.02

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 61.09 61.23 61.23 61.33 61.33
anjanaben jigishkumar des... 0.48 0.48 0.48 0.48 0.48
chetan chandrakant jariwa... 15.07 15.07 15.07 15.07 15.07
hardik jigishkumar desai 43.96 39.46 34.96 34.96 34.96
hardik jigishkumar desai,... - 4.64 9.14 9.14 9.14
kailashben chandrakant ja... 0.21 0.21 0.21 0.21 0.21
maniya hardik desai 1.17 1.17 1.17 1.17 1.17
rupaben chetanbhai jariwa... 0.19 0.19 0.19 0.19 0.19
trident lifeline limited - - - 0.10 0.10
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 38.91 38.77 38.77 38.67 38.67
il and fs securities serv... 1.31 1.31 1.31 1.31 1.31
amit bhupendrabhai halvaw... - - - 1.00 -
dhavl shah 1.43 1.43 1.43 1.43 -
narshibhai meghjibhai mer... 1.04 1.04 1.04 1.04 -
shravan h patel 1.81 1.82 1.82 1.82 -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ4FY21 29 Jul 2021
  • PresentationQ3FY24 19 Feb 2024
  • PresentationQ2FY22 30 Oct 2021
  • PresentationQ2FY21 17 Nov 2020

Company News

Trident Texofab - Quaterly Results14 Feb 2024, 6:29PM Trident Texofab - Quaterly Results6 Nov 2023, 6:16PM Trident Texofab - Quaterly Results6 Nov 2023, 6:16PM Trident Texofab - Quaterly Results10 Aug 2023, 6:32PM Trident Texofab - Quaterly Results24 Apr 2023, 8:33PM Trident Texofab - Quaterly Results24 Apr 2023, 8:33PM Trident Texofab informs about outcome of board meeting29 Mar 2023, 2:38PM Trident Texofab informs about disclosure 25 Mar 2023, 3:32PM Trident Texofab informs about disclosure 1 Mar 2023, 4:54PM Trident Texofab informs about disclosure 1 Feb 2023, 5:18PM Trident Texofab informs about press release18 Jan 2023, 4:28PM Trident Texofab - Quaterly Results16 Jan 2023, 2:11PM Trident Texofab - Quaterly Results16 Jan 2023, 2:11PM Trident Texofab - Quaterly Results16 Jan 2023, 2:11PM Trident Texofab informs about press release7 Dec 2022, 12:34PM Trident Texofab informs about compliances-certificate15 Oct 2022, 3:50PM Trident Texofab informs about board meeting proceedings11 Oct 2022, 5:04PM Trident Texofa informs about outcome of board meeting11 Oct 2022, 5:02PM Trident Texofab - Quaterly Results11 Oct 2022, 1:24PM Trident Texofab - Quaterly Results11 Oct 2022, 1:24PM Trident Texofab - Quaterly Results11 Oct 2022, 1:24PM Trident Texofab to raise Rs 12 crore through NCDs19 Sep 2022, 10:30AM Trident Texofab - Quaterly Results12 Jul 2022, 4:59PM Trident Texofab - Quaterly Results12 Jul 2022, 4:59PM Trident Texofab - Quaterly Results12 Jul 2022, 4:59PM Trident Texofab informs about disclosure6 Jun 2022, 10:13AM Trident Texofab - Quaterly Results21 Apr 2022, 5:54PM Trident Texofab - Quaterly Results21 Apr 2022, 5:54PM Trident Texofab - Quaterly Results21 Apr 2022, 5:54PM Trident Texofab - Quaterly Results19 Jan 2022, 5:54PM Trident Texofab - Quaterly Results19 Jan 2022, 5:54PM Trident Texofab informs about disclosure29 Dec 2021, 4:50PM Trident Texofab informs about disclosures23 Dec 2021, 5:02PM Trident Texofab informs about disclosure6 Dec 2021, 5:19PM Trident Texofab informs about disclosure6 Dec 2021, 5:01PM Trident Texofab informs about investor presentation27 Oct 2021, 2:39PM Trident Texofab informs about certificate7 Oct 2021, 3:51PM Trident Texofab informs about disclosure 4 Oct 2021, 1:21PM Trident Texofab informs about proceedings of 13th AGM21 Sep 2021, 1:28PM Trident Texofab informs about newspaper publication16 Sep 2021, 4:37PM Trident Texofab informs about calendar of events for conducting postal ballot16 Sep 2021, 4:34PM Trident Texofab informs about outcome of board meeting14 Sep 2021, 4:00PM Trident Texofab informs about postal ballot notice14 Sep 2021, 2:45PM Trident Texofab informs about newspaper advertisement31 Aug 2021, 3:22PM Trident Texofab informs about outcome of board meeting11 Mar 2021, 12:47PM Trident Texofab submits newspaper advertisements 6 Feb 2021, 12:53PM Trident Texofab informs about disclosure24 Nov 2020, 3:21PM

Trident Texofab Stock Price Analysis and Quick Research Report. Is Trident Texofab an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Trident Texofab has a PE ratio of 39.6781534460338 which is high and comparatively overvalued .

  • Share Price: - The current share price of Trident Texofab is Rs 48.82. One can use valuation calculators of ticker to know if Trident Texofab share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Trident Texofab has ROA of 2.99187228708164 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Trident Texofab has a Current ratio of 1.25388013804402 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Trident Texofab has a ROE of 15.7986006017768 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Trident Texofab has a D/E ratio of 2.2864 which means that the company has high proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Trident Texofab has an Inventory turnover ratio of 10.8463557079206 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Trident Texofab has reported revenue growth of 14.3187138214835 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Trident Texofab for the current financial year is 6.54678446630557 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Trident Texofab is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Trident Texofab
X